210 related articles for article (PubMed ID: 26534724)
1. Aging increases the susceptibility of cisplatin-induced nephrotoxicity.
Wen J; Zeng M; Shu Y; Guo D; Sun Y; Guo Z; Wang Y; Liu Z; Zhou H; Zhang W
Age (Dordr); 2015 Dec; 37(6):112. PubMed ID: 26534724
[TBL] [Abstract][Full Text] [Related]
2. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
[TBL] [Abstract][Full Text] [Related]
3. Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice.
Oda M; Koyanagi S; Tsurudome Y; Kanemitsu T; Matsunaga N; Ohdo S
Mol Pharmacol; 2014 May; 85(5):715-22. PubMed ID: 24567546
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study.
Ikemura K; Oshima K; Enokiya T; Okamoto A; Oda H; Mizuno T; Ishinaga H; Muraki Y; Iwamoto T; Takeuchi K; Katayama N; Okuda M
Cancer Chemother Pharmacol; 2017 May; 79(5):943-949. PubMed ID: 28364288
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity.
Volarevic V; Djokovic B; Jankovic MG; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N
J Biomed Sci; 2019 Mar; 26(1):25. PubMed ID: 30866950
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
8. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
[TBL] [Abstract][Full Text] [Related]
9. Age-related differences in kidney injury biomarkers induced by cisplatin.
Shin YJ; Kim TH; Won AJ; Jung JY; Kwack SJ; Kacew S; Chung KH; Lee BM; Kim HS
Environ Toxicol Pharmacol; 2014 May; 37(3):1028-39. PubMed ID: 24751685
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective activity of Ribes diacanthum pall (RDP) against inflammation in cisplatin-stimulated mice model and human renal tubular epithelial cells.
Wu Y; Zhao L; Gu L; Tilyek A; Yu B; Chai C
J Ethnopharmacol; 2022 Jan; 283():114696. PubMed ID: 34601083
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
[TBL] [Abstract][Full Text] [Related]
12. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
Saad SY; Arafah MM; Najjar TA
Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats.
Uchino H; Matsumura Y; Negishi T; Koizumi F; Hayashi T; Honda T; Nishiyama N; Kataoka K; Naito S; Kakizoe T
Br J Cancer; 2005 Sep; 93(6):678-87. PubMed ID: 16222314
[TBL] [Abstract][Full Text] [Related]
14. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
Saad SY; Al-Rikabi AC
Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
[TBL] [Abstract][Full Text] [Related]
15. Reduction of cisplatin toxicity and lethality by sodium malate in mice.
Ueda H; Sugiyama K; Yokota M; Matsuno K; Ezaki T
Biol Pharm Bull; 1998 Jan; 21(1):34-43. PubMed ID: 9477166
[TBL] [Abstract][Full Text] [Related]
16. Vanadium(III)-L-cysteine protects cisplatin-induced nephropathy through activation of Nrf2/HO-1 pathway.
Basu A; Singha Roy S; Bhattacharjee A; Bhuniya A; Baral R; Biswas J; Bhattacharya S
Free Radic Res; 2016; 50(1):39-55. PubMed ID: 26573721
[TBL] [Abstract][Full Text] [Related]
17. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Cisplatin-Induced Nephrotoxicity: A Multicenter Retrospective Study.
Miyoshi T; Uoi M; Omura F; Tsumagari K; Maesaki S; Yokota C
Oncology; 2021; 99(2):105-113. PubMed ID: 32966986
[TBL] [Abstract][Full Text] [Related]
19. Relationship between age and nephrotoxicity following single low-dose cisplatin (CDDP) injection in rats.
Namikawa K; Kinsoku A; Minami T; Okazaki Y; Kadota E; Teramura K; Hashimoto S
Biol Pharm Bull; 1995 Jul; 18(7):957-62. PubMed ID: 7581250
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression.
Sogawa N; Hirai K; Sogawa C; Ohyama K; Miyazaki I; Tsukamoto G; Asanuma M; Sasaki A; Kitayama S
Life Sci; 2013 Apr; 92(12):727-32. PubMed ID: 23399700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]